AI in Medical Imaging Market Surges Toward USD 22.97 Trillion by 2035 Amid Rapid Clinical Adoption and AI Innovation

AI-Powered Diagnostics Transform Healthcare with Double-Digit Growth Trajectory

The global AI in medical imaging market is witnessing a transformative surge, projected to grow from USD 5.9 billion in 2024 to approximately USD 34.8 billion by 2034, expanding at a robust CAGR of 19.4%. The rapid integration of artificial intelligence across diagnostic imaging workflows, coupled with the growing burden of chronic diseases and demand for faster, more accurate diagnostics, is driving unprecedented market expansion.

Healthcare providers are increasingly leveraging AI-powered tools to enhance diagnostic precision, reduce radiologist workload, and improve patient outcomes. From early disease detection to automated image interpretation, AI is redefining how medical imaging is practiced globally.

AI In Medical Imaging Market Size 2026 To 2035

Quick Insights: What’s Driving the AI in Medical Imaging Market?

The market is expected to reach nearly USD 34.8 billion by 2034, reflecting strong long-term growth momentum.
North America currently leads the global market due to advanced healthcare infrastructure and early AI adoption.
Radiology remains the dominant application segment, driven by high imaging volumes and AI integration.
Deep learning technology holds the largest share due to its superior image recognition capabilities.
Key players such as GE HealthCare, Siemens Healthineers, and Philips Healthcare are actively innovating in AI-powered imaging solutions.

How is AI Revolutionizing Medical Imaging?

Artificial intelligence is transforming medical imaging by enabling automated detection of abnormalities, reducing diagnostic errors, and accelerating clinical workflows. Advanced algorithms can now analyze imaging data such as CT scans, MRIs, and X-rays with remarkable accuracy, often matching or exceeding human radiologists in specific tasks.

Moreover, AI is enabling predictive analytics in imaging, helping clinicians identify disease progression patterns and personalize treatment plans. This shift from reactive to proactive healthcare is one of the most significant contributions of AI in the imaging domain.

AI in Medical Imaging Market Scope

Report Coverage Details
Market Size in 2025 USD 2.01 Trillion
Market Size in 2026 USD 2.57 Trillion
Market Size by 2035 USD 22.97 Trillion
Growth Rate from 2026 to 2035 CAGR of 27.57%
Base Year 2025
Forecast Period 2026 to 2035
Segments Covered Clinical Area, Technology Type, Deployment Type, Imaging Modality, Functionality, Product Type, End User, and Region
Regions Covered North America, Europe, Asia-Pacific, South America, and Middle East & Africa

What are the Key Growth Drivers of the Market?

The growth of the AI in medical imaging market is primarily fueled by the increasing prevalence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders. These conditions require early and accurate diagnosis, which AI significantly enhances.

Additionally, the global shortage of skilled radiologists has created a pressing need for automated solutions. AI bridges this gap by improving efficiency and reducing workload, allowing healthcare professionals to focus on complex cases. Rising healthcare digitization and investments in AI-based healthcare infrastructure further accelerate market growth.

What Opportunities and Trends are Shaping the Market?
Is AI Becoming a Standard Tool in Radiology Departments?

Yes, AI is rapidly becoming an integral part of radiology workflows. Hospitals and diagnostic centers are adopting AI tools for routine screening, triaging, and reporting, significantly improving turnaround times.

Are Emerging Markets Creating New Growth Avenues?

Absolutely. Developing regions are witnessing increased adoption of AI-driven imaging due to improving healthcare infrastructure and rising awareness of advanced diagnostic tools.

What Role Does Cloud-Based AI Play?

Cloud deployment is emerging as a key trend, enabling scalable, cost-effective AI solutions accessible to smaller healthcare providers without heavy infrastructure investments.

Segmental Insights

Clinical Area Insights

In 2025, lung and pulmonary applications held the largest share (22%) of the AI in medical imaging market. This dominance is mainly due to the high number of chest imaging procedures performed globally. The rising cases of respiratory diseases such as pneumonia, COPD, and tuberculosis have significantly increased the need for AI-supported diagnostics.

Within this category, non-cancerous lung conditions accounted for the biggest portion, as AI tools are increasingly helping doctors detect diseases earlier and make better clinical decisions. The widespread use of chest X-rays and CT scans has also contributed to this segment’s leadership.

Meanwhile, the oncology segment is expected to grow the fastest in the coming years. This growth is driven by the increasing global burden of cancer and the need for early and accurate diagnosis. AI is playing a major role in detecting tumors, analyzing their progression, and supporting treatment planning. Advancements in precision medicine and personalized cancer care are further boosting this segment.

Technology Type Insights

Among different technologies, deep learning led the market with a 48% share in 2025. In particular, convolutional neural networks (CNNs) are widely used because they perform exceptionally well in image recognition, classification, and segmentation tasks. Their reliability and accuracy have made them the backbone of most AI imaging applications.

On the other hand, explainable AI (XAI) is expected to grow at the fastest pace. As healthcare professionals increasingly demand transparency in AI-driven decisions, XAI helps by showing how models arrive at their conclusions. This improves trust, usability, and aligns with regulatory requirements for ethical AI use.

Deployment Mode Insights

On-premise deployment dominated the market in 2025, accounting for 58% of the share. Hospitals prefer this approach because it offers better data security and compliance with healthcare regulations. It also allows smoother integration with existing hospital IT systems.

However, edge or embedded AI solutions are expected to grow the fastest. These systems enable real-time image processing with minimal delay, making them especially useful in emergency and critical care situations where quick decisions are crucial.

AI in Medical Imaging Market Share, By Deployment Type, 2025 (%)

Imaging Modality Insights

CT scans held the largest market share (37%) in 2025 due to their extensive use in diagnosing lung diseases, cancer, and trauma cases. AI integration in CT imaging improves detection accuracy and enhances workflow efficiency, reinforcing its dominant position.

MRI is projected to be the fastest-growing modality. Its increasing use in neurology, oncology, and musculoskeletal imaging is driving demand. AI helps improve image quality, reduce scan times, and provide more precise diagnoses, making MRI an increasingly attractive option.

Functionality Insights

Image analysis was the leading functionality segment, capturing 51% of the market in 2025. This is because it forms the core of most AI imaging applications. AI-powered tools help in detecting abnormalities, segmenting images, and quantifying medical conditions more accurately.

As healthcare providers aim to reduce workload and improve diagnostic precision, automated image analysis has become widely adopted across medical facilities.

Product Type Insights

Software solutions dominated the market with a 77% share in 2025. Their popularity comes from easy integration into existing systems, scalability, and the ability to update without requiring major hardware changes.

At the same time, AI-enabled hardware is gaining traction. With the integration of AI processors directly into imaging devices, healthcare providers can achieve faster and real-time image processing. Continuous advancements in smart imaging equipment are expected to drive this segment’s growth.

End User Insights

Hospitals were the largest end users, holding 65% of the market share in 2025. Their high patient volumes, advanced infrastructure, and strong financial capacity make them early adopters of AI technologies.

Diagnostic imaging centers, however, are expected to grow the fastest. The increasing demand for outpatient imaging services is pushing these centers to adopt AI solutions to improve efficiency and reduce turnaround times. Competitive pressure is also encouraging faster adoption.

Regional Insights

North America

North America led the global market with a 45% share in 2025. This is due to the presence of major industry players, supportive government policies, and strong adoption across healthcare institutions.

The United States and Canada are expected to remain key contributors, with ongoing investments in research, innovation, and AI-driven healthcare solutions.

Asia Pacific

Asia Pacific is the fastest-growing region, driven by rising healthcare needs, rapid technological advancements, and supportive government initiatives. Countries like India, China, and Australia are actively adopting AI to improve diagnostic accuracy and efficiency.

In India, the growth of health-tech startups and government programs such as the Ayushman Bharat Digital Mission are accelerating adoption. In China, AI technologies are transforming clinical decision-making in hospitals, while Australia is integrating AI into public radiology services.

Europe

Europe is expected to see steady growth, supported by strong healthcare systems and regulatory backing. Countries like Germany, the UK, and Spain are leading in AI adoption for diagnostics.

Collaborations between healthcare providers and technology companies, along with investments in AI research, are driving innovation and improving patient outcomes across the region.

South America

South America is emerging as a promising market due to increasing healthcare digitization and a growing need for accurate diagnostics. Investments in imaging infrastructure and AI technologies are improving early disease detection and workflow efficiency.

Cloud-based solutions are helping overcome cost and infrastructure challenges, while partnerships between global and local players are accelerating adoption.

Middle East & Africa

The Middle East & Africa region is gradually expanding, supported by healthcare modernization efforts and rising investments in diagnostic technologies.

In the Middle East, government-led digital health initiatives are driving early adoption, especially in Gulf countries. In Africa, AI is helping improve access to diagnostics in underserved areas through scalable and cloud-based solutions.

AI in Medical Imaging Market Companies

  • Agfa-Gevaert Group
  • Ada Health
  • Enlitic Inc
  • CELLMATIQ GMBH
  • GENERAL ELECTRIC COMPANY
  • IBM
  • NVIDIA CORPORATION
  • MICROSOFT
  • KONINKLIJKE PHILIPS N.V.
  • SIEMENS

Segments Covered in the Report

By Clinical Area

  • Lung/Pulmonary
    • Lung cancer
    • Non-cancer lung diseases
  • Brain/Neurology
    • Stroke/Haemorrhage
    • Dementia & Neurodegenerative Diseases
    • Brain Tumors/Lesions
  • Heart/Cardiology
    • Coronary Artery Diseases
    • Heart Failure & Functional Assessment
    • Congenital & Structural Heart Diseases
  • Oncology
  • Musculoskeletal
  • Gastroenterology/Hepatology
  • Ophthalmology
  • Other Specialities (Obstetrics/Gynaecology, Urology, Dermatology)

By Technology Type

  • Machine Learning
  • Deep Learning
    • CNN
    • RNN/LSTM
    • Transformers/ViTs
    • Generative Models (GANs, Diffusers)
  • Natural Language Processing (NLP)
  • Hybrid/ Multimodal AI
  • Explainable AI (XAI)

By Deployment Type

  • On-premise
  • Cloud-based
  • Hybrid
  • Edge/Embedded

By Imaging Modality

  • X-ray
  • CT Scan
  • MRI
  • Ultrasound
  • PET/SPECT
  • Other Imaging Modalities

By Functionality

  • Image Acquisition & Reconstruction
  • Image Enhancement &Processing
  • Image Analysis
    • Segmentation
    • Detection
    • Classification
    • Quantification
  • Workflow & Reporting
  • Predictive & Prognostic Analytics

By Product Type

  • Software
    • AI Analysis Software
    • AI Workflow & Reporting Tools
  • AI-enabled Hardware
    • Imaging Device with Embedded AI (CT, MRI, X-ray, Ultrasound)
    • Edge/AI Workstations
    • AI Accelerators

By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Research & Academic Institutes

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa (MEA)

Get Sample Link: https://www.precedenceresearch.com/sample/2380

Also Read : https://www.businesswebwire.com/wp-admin/post.php?post=2141&action=edit

Scroll to Top